While Abivax ADR has underperformed by -2.06%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ABVX rose by 1844.13%, with highs and lows ranging from $148.83 to $4.77, whereas the simple moving average jumped by 159.12% in the last 200 days.
On November 24, 2025, Truist started tracking Abivax ADR (NASDAQ: ABVX) recommending Buy. A report published by Wolfe Research on November 06, 2025, Initiated its previous ‘Outperform’ rating for ABVX. Barclays also rated ABVX shares as ‘Overweight’, setting a target price of $142 on the company’s shares in an initiating report dated October 13, 2025. Morgan Stanley initiated its ‘Equal-Weight’ rating for ABVX, as published in its report on March 20, 2025. JMP Securities’s report from December 04, 2024 suggests a price prediction of $33 for ABVX shares, giving the stock a ‘Mkt Outperform’ rating. Laidlaw also rated the stock as ‘Buy’.
Analysis of Abivax ADR (ABVX)
In order to gain a clear picture of Abivax ADR’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -147.48% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.86, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 1.39M can be a very valuable indicator of volatility for ABVX stock. On a monthly basis, the volatility of the stock is set at 5.79%, whereas on a weekly basis, it is put at 5.12%, with a gain of 25.26% over the past seven days. Furthermore, long-term investors anticipate a median target price of $141.57, showing decline from the present price of $142.31, which can serve as yet another indication of whether ABVX is worth investing in or should be passed over.
How Do You Analyze Abivax ADR Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 11.60%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 55.59% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
